Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.499, 2006-01, pp. : 7-7
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Adjuvant letrozole worth the extra costs . . .
Inpharma, Vol. 1, Iss. 1530, 2006-01 ,pp. :
Access to resources
Recommend
Low rate of cardiovascular AEs with adjuvant letrozole, tamoxifen
Reactions Weekly, Vol. 1, Iss. 1182, 2007-01 ,pp. :
A delay is okay with adjuvant letrozole in early breast cancer
Inpharma, Vol. 1, Iss. 1630-1631, 2008-01 ,pp. :
Amifostine worth extra cost in treating solid tumours
Inpharma, Vol. 1, Iss. 1281, 2001-01 ,pp. :
Amifostine worth extra cost in treating solid tumours
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 306, 2001-01 ,pp. :